Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 10 Sarcoma 9 Lung Neoplasms 6 Uterine Cervical Neoplasms 5 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Neoplasms 3 Liposarcoma, Myxoid 3 Head and Neck Neoplasms 3 Glioblastoma 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Urogenital Neoplasms 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Synovial 2 Radiation Injuries 2 Neurofibrosarcoma 2 Neoplasm Metastasis 2 Melanoma 2 Lymphatic Metastasis 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Cholangiocarcinoma 2

Interventions

Cyclophosphamide 25 Temozolomide 22 Vincristine 18 Irinotecan 18 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 regorafenib 5 fludarabine 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Radiotherapy 5 Gemcitabine 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 irinotecan sucrosofate 4 ganitumab 4 fludarabine phosphate 4 Trabectedin 4 Phantoms, Imaging 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Radiation Dose Hypofractionation × Clear all

NCT07188532 2026-06-04

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡